Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets

Benjamin D. Greenberg, Teresa J. Tolliver, Su Jan Huang, Qian Li, Dietmar Bengel, Dennis L. Murphy

Research output: Contribution to journalArticle

Abstract

The human serotonin transporter (5-HTT), encoded by a single gene on chromosome 17q11.2, is expressed in brain and blood cells. 5-HTT is implicated in mood and anxiety regulation, and is where antidepressant and antianxiety drugs initially act in the brain. A 5-HTT-linked promoter region (5HTTLPR) insertion]deletion polymorphism with long (l) and short (s) forms affects transporter expression and function. The s variant reduced 5-HTT gene transcription in a reporter gene construct and human lymphoblasts, resulting in reduced transporter levels and 5-HT uptake, acting as a dominant allele. In this study, we investigated the expression and function of 5-HTT in platelets from healthy male volunteers. The I variant was associated with more rapid initial platelet 5-HT uptake (V(max)), the index of platelet 5- HTT function most clearly heritable, while the s allele was dominant. The 5- HTTLPR genotype had no effect on platelet [3H]paroxetine binding (B(max)), affinity for [3H]5-HT or [3H]paroxetine, or 5-HT content. The 5-HT uptake findings support a functional difference in the two 5-HTTLPR variants, reinforcing their attractiveness as candidate genes in neuropsychiatric research.

Original languageEnglish (US)
Pages (from-to)83-87
Number of pages5
JournalAmerican Journal of Medical Genetics - Neuropsychiatric Genetics
Volume88
Issue number1
DOIs
StatePublished - Feb 5 1999
Externally publishedYes

Fingerprint

Serotonin Plasma Membrane Transport Proteins
Genetic Promoter Regions
Serotonin
Blood Platelets
Paroxetine
Alleles
Genes
Brain
Reporter Genes
Antidepressive Agents
Blood Cells
Healthy Volunteers
Anxiety
Chromosomes
Genotype
Research

Keywords

  • Genetic variants
  • Platelet serotonin uptake
  • Serotonin transporter promoter

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)

Cite this

Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. / Greenberg, Benjamin D.; Tolliver, Teresa J.; Huang, Su Jan; Li, Qian; Bengel, Dietmar; Murphy, Dennis L.

In: American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 88, No. 1, 05.02.1999, p. 83-87.

Research output: Contribution to journalArticle

Greenberg, Benjamin D. ; Tolliver, Teresa J. ; Huang, Su Jan ; Li, Qian ; Bengel, Dietmar ; Murphy, Dennis L. / Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. In: American Journal of Medical Genetics - Neuropsychiatric Genetics. 1999 ; Vol. 88, No. 1. pp. 83-87.
@article{ea8c383cb11c40959813e404e44b4daf,
title = "Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets",
abstract = "The human serotonin transporter (5-HTT), encoded by a single gene on chromosome 17q11.2, is expressed in brain and blood cells. 5-HTT is implicated in mood and anxiety regulation, and is where antidepressant and antianxiety drugs initially act in the brain. A 5-HTT-linked promoter region (5HTTLPR) insertion]deletion polymorphism with long (l) and short (s) forms affects transporter expression and function. The s variant reduced 5-HTT gene transcription in a reporter gene construct and human lymphoblasts, resulting in reduced transporter levels and 5-HT uptake, acting as a dominant allele. In this study, we investigated the expression and function of 5-HTT in platelets from healthy male volunteers. The I variant was associated with more rapid initial platelet 5-HT uptake (V(max)), the index of platelet 5- HTT function most clearly heritable, while the s allele was dominant. The 5- HTTLPR genotype had no effect on platelet [3H]paroxetine binding (B(max)), affinity for [3H]5-HT or [3H]paroxetine, or 5-HT content. The 5-HT uptake findings support a functional difference in the two 5-HTTLPR variants, reinforcing their attractiveness as candidate genes in neuropsychiatric research.",
keywords = "Genetic variants, Platelet serotonin uptake, Serotonin transporter promoter",
author = "Greenberg, {Benjamin D.} and Tolliver, {Teresa J.} and Huang, {Su Jan} and Qian Li and Dietmar Bengel and Murphy, {Dennis L.}",
year = "1999",
month = "2",
day = "5",
doi = "10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.0.CO;2-0",
language = "English (US)",
volume = "88",
pages = "83--87",
journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets

AU - Greenberg, Benjamin D.

AU - Tolliver, Teresa J.

AU - Huang, Su Jan

AU - Li, Qian

AU - Bengel, Dietmar

AU - Murphy, Dennis L.

PY - 1999/2/5

Y1 - 1999/2/5

N2 - The human serotonin transporter (5-HTT), encoded by a single gene on chromosome 17q11.2, is expressed in brain and blood cells. 5-HTT is implicated in mood and anxiety regulation, and is where antidepressant and antianxiety drugs initially act in the brain. A 5-HTT-linked promoter region (5HTTLPR) insertion]deletion polymorphism with long (l) and short (s) forms affects transporter expression and function. The s variant reduced 5-HTT gene transcription in a reporter gene construct and human lymphoblasts, resulting in reduced transporter levels and 5-HT uptake, acting as a dominant allele. In this study, we investigated the expression and function of 5-HTT in platelets from healthy male volunteers. The I variant was associated with more rapid initial platelet 5-HT uptake (V(max)), the index of platelet 5- HTT function most clearly heritable, while the s allele was dominant. The 5- HTTLPR genotype had no effect on platelet [3H]paroxetine binding (B(max)), affinity for [3H]5-HT or [3H]paroxetine, or 5-HT content. The 5-HT uptake findings support a functional difference in the two 5-HTTLPR variants, reinforcing their attractiveness as candidate genes in neuropsychiatric research.

AB - The human serotonin transporter (5-HTT), encoded by a single gene on chromosome 17q11.2, is expressed in brain and blood cells. 5-HTT is implicated in mood and anxiety regulation, and is where antidepressant and antianxiety drugs initially act in the brain. A 5-HTT-linked promoter region (5HTTLPR) insertion]deletion polymorphism with long (l) and short (s) forms affects transporter expression and function. The s variant reduced 5-HTT gene transcription in a reporter gene construct and human lymphoblasts, resulting in reduced transporter levels and 5-HT uptake, acting as a dominant allele. In this study, we investigated the expression and function of 5-HTT in platelets from healthy male volunteers. The I variant was associated with more rapid initial platelet 5-HT uptake (V(max)), the index of platelet 5- HTT function most clearly heritable, while the s allele was dominant. The 5- HTTLPR genotype had no effect on platelet [3H]paroxetine binding (B(max)), affinity for [3H]5-HT or [3H]paroxetine, or 5-HT content. The 5-HT uptake findings support a functional difference in the two 5-HTTLPR variants, reinforcing their attractiveness as candidate genes in neuropsychiatric research.

KW - Genetic variants

KW - Platelet serotonin uptake

KW - Serotonin transporter promoter

UR - http://www.scopus.com/inward/record.url?scp=0033525170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033525170&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.0.CO;2-0

DO - 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.0.CO;2-0

M3 - Article

C2 - 10050973

AN - SCOPUS:0033525170

VL - 88

SP - 83

EP - 87

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

SN - 1552-4841

IS - 1

ER -